Segal Lloyd Mitchell 4
4 · Repare Therapeutics Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Shares
2024-03-01+40,000→ 124,677 total - Award
Employee Stock Option (right to buy)
2024-03-01+237,000→ 237,000 totalExercise: $6.95Exp: 2034-02-28→ Common Shares (237,000 underlying)
Holdings
- 94,466(indirect: See footnote)
Common Shares
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 1, 2025, March 1, 2026 and March 1, 2027, subject to Reporting Person continuing to provide service through each such date.
- [F2]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
- [F3]Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.